BR

Bioline Rx

BLRX
TEL AVIV STOCK EXCHANGEHealth Care
$3.37
USD
-0.10(-2.88%)
At close: Jun 12, 20:00 UTC

Open

$3.43

Prev. Close

$3.43

High

$3.43

Low

$3.37

Market Snapshot

Market Cap

$17.6M

P/E Ratio

-2.0

Revenue

$28.94M

Employees

24

About

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. The company is headquartered in Modiin, Central(Hamerkaz) and currently employs 24 full-time employees. The company went IPO on 2007-01-30. The firm is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The firm is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.

Recently from Cashu